Source: Wyeth PharmaceuticalsWyeth Pharmaceuticals.

The CHMP recommends approval of Prevenar 13 for active immunization of children aged 6 weeks to 5 years for the prevention of invasive pneumococcal disease, as well as pneumonia and otitis media caused by 13 pneumococcal serotypes. The CHMP opinion for Prevenar 13 will now be forwarded to the European Commission and a in the coming months in the coming months. 19F, and 23F’The CHMP ‘s positive opinion brings us one step closer to providing infants and young children in Europe with the broadest serotype coverage of all pneumococcal conjugate vaccine,’says Emilio Emini, Executive Vice President, Vaccine Research and Development, Wyeth Pharmaceuticals. ‘Prevenar, our currently available vaccine, has both proven clinical efficacy and documented effectiveness , which has resulted in a significant public health benefits.

Wyeth PharmaceuticalsWyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women’s health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.‘There plays a big part treated handled and stored fatty,’says Lazar. ‘It also underscores the importance of compliance with our internal circadian clock. For example, because our bodies can not assume that Food & Drink to create at night and prepares for view more glucose, night Dining – probably shoot blood glucose and can thus help diabetes.. The results indicate that the coated barrier of lipids in liver at many tiny drop help you manage insulin resistance in the body. And cementing the results of the fact that HDAC3 be pivoted in the integration of signals from the inner clock order to coordinate the metabolism, primarily by the liver J.

Other entries from category "prevention":

Tag Cloud